文献速递腹部心血管骨肌CT

基于AI的腹部CT机会性筛查心血管病、骨质疏松和肌少症的成本效果分析

AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis.
PubMed 文献 · Abdom Radiol (NY) · 2023-01-20

本研究通过构建Markov模型对10,000名美国成年人进行10年模拟,评估AI辅助腹部CT机会性筛查动脉粥样硬化性心血管病、骨质疏松和肌少症的成本效果与临床效益。结果显示,与不治疗和普遍他汀治疗相比,AI辅助CT机会性筛查在基础案例中更具成本节约性和临床有效性,且在广泛输入假设下均占优。

要点

  • AI辅助腹部CT机会性筛查在55岁男女10年模拟中更有效且节约成本。
  • 该策略在广泛假设下均优于不治疗和普遍他汀治疗。
  • 男性AI工具成本达227美元/人、女性65美元/人时仍节约成本。

诊断标准与关键数值

  • AI辅助CT机会性筛查使用自动定量算法评估腹主动脉钙化、骨密度和骨骼肌,分别对应心血管病、骨质疏松和肌少症。

临床应用与阅片要点

  • 可利用腹部CT机会性评估腹主动脉钙化、骨密度和骨骼肌,辅助筛查相关疾病。
  • 在报告中可提示机会性发现,但需注意 AI 工具成本阈值(男性227美元/人、女性65美元/人)对成本效果的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the cost-effectiveness and clinical efficacy of AI-assisted abdominal CT-based opportunistic screening for atherosclerotic cardiovascular (CV) disease, osteoporosis, and sarcopenia using artificial intelligence (AI) body composition algorithms.

METHODS: Markov models were constructed and 10-year simulations were performed on hypothetical age- and sex-specific cohorts of 10,000 U.S. adults (base case: 55 year olds) undergoing abdominal CT. Using expected disease prevalence, transition probabilities between health states, associated healthcare costs, and treatment effectiveness related to relevant conditions (CV disease/osteoporosis/sarcopenia) were modified by three mutually exclusive screening models: (1) usual care ("treat none"; no intervention regardless of opportunistic CT findings), (2) universal statin therapy ("treat all" for CV prevention; again, no consideration of CT findings), and (3) AI-assisted abdominal CT-based opportunistic screening for CV disease, osteoporosis, and sarcopenia using automated quantitative algorithms for abdominal aortic calcification, bone mineral density, and skeletal muscle, respectively. Model validity was assessed against published clinical cohorts.

RESULTS: For the base-case scenarios of 55-year-old men and women modeled over 10 years, AI-assisted CT-based opportunistic screening was a cost-saving and more effective clinical strategy, unlike the "treat none" and "treat all" strategies that ignored incidental CT body composition data. Over a wide range of input assumptions beyond the base case, the CT-based opportunistic strategy was dominant over the other two scenarios, as it was both more clinically efficacious and more cost-effective. Cost savings and clinical improvement for opportunistic CT remained for AI tool costs up to $227/patient in men ($65 in women) from the $10/patient base-case scenario.

CONCLUSION: AI-assisted CT-based opportunistic screening appears to be a highly cost-effective and clinically efficacious strategy across a broad array of input assumptions, and was cost saving in most scenarios.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Pickhardt, Correale, Hassan, et al. AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis. Abdom Radiol (NY). 2023. PMID: 36670245. doi:10.1007/s00261-023-03800-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。